Building on its strong foundation in Pakistan’s pharmaceutical industry, Amarant Pharma (Pvt.) Ltd. is expanding its reach globally, striving to make high-quality, affordable medicines accessible to millions. Our cutting-edge, cGMP-compliant manufacturing facility in Karachi, Pakistan, forms the backbone of this mission
Global Presence
International Business
Amarant Pharma’s International Business Department is ambitiously extending its operations beyond borders. Currently, we are present in Afghanistan and Sri Lanka, supported by dedicated Sales and Marketing teams. Additionally, we have secured product registrations in Senegal, the Philippines, and Madagascar, with upcoming team launches in these markets. Our regional office in Dubai, UAE, serves as a hub for strategic operations and growth.
Unlike traditional pharmaceutical trading, we focus on building strong, recognized brands through innovative marketing strategies. Our Neuropsychiatry portfolio, in particular, has attracted thousands of international customers, further strengthening our global presence.
Current Achievements
- Exporting over 50 products to international markets.
- Ongoing new product registrations to meet global demand.
- Committed to meeting stringent international regulatory standards through continuous improvements in quality and systems.
Future Outlook
With ambitious global expansion plans, guided by our Vision 2022, we aim to establish a robust presence in Africa, the Middle East, ASEAN, and CIS regions. Prospective markets include Kenya, Tanzania, Ethiopia, the Democratic Republic of Congo, Cameroon, Ghana, Namibia, Zambia, Angola, Chad, Sudan, Madagascar, Mauritius, Yemen, Cambodia, Myanmar, Laos, Kazakhstan, Uzbekistan, and Tajikistan.
Amarant Pharma is dedicated to forming close partnerships based on trust and mutual respect, ensuring sustainable growth and success in every market we enter.